Search - tctmd.com

Displaying 121 - 140 of 209

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Does Tricuspid Leaflet Grasping Make Sense As a Primary or Adjunctive TR Therapy?

Presenter: Georg Nickenig

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

One-stop Shopping: Once TMVR Is Refined, Clearly the Preferred Therapy for Most MR Patients

Presenter: Martin B. Leon

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Leaflet Chordal Suspension for Primary MR Will Importantly Augment the Surgical/Interventional Toolbox

Presenter: David H. Adams

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Transcatheter Mitral Annuloplasty Devices Will Be the "Centerpiece" in the Future

Presenter: Steven F. Bolling

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cant Beat Safety and Simplicity: Transcatheter Leaflet Approximation Technologies Will Continue to Dominate

Presenter: Ted Feldman

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

NO: The Data Are Weak and the Costs Are Prohibitive!

Presenter: John K. Forrest

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

YES: Review of ALL the Data and Common Sense Tell the Story!

Presenter: Axel Linke

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cedars-Sinai Medical Center (USA)

Presenter: Tarun Chakravarty

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Erasmus University (The Netherlands)

Presenter: Nicolas M. Van Mieghem

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Ulm University (Germany)

Presenter: Julia Seeger

June 21, 2018

Presentation TCT 2017

Flash Debate 3: Should the Rapidly Improving and Asymptomatic Patient With Significant Vessel Occlusion Be Treated (and When)? No!

Presenter: Nick Hopkins, Aman B. Patel

November 01, 2017

Presentation TCT 2017

Flash Debate 3: Should the Rapidly Improving and Asymptomatic Patient With Significant Vessel Occlusion Be Treated (and When)? Yes!

Presenter: Nick Hopkins, Aman B. Patel, Adnan Siddiqui

November 01, 2017

Presentation TCT 2017

Flash Debate 2: I Favor Conscious Sedation Over General Anesthesia in Acute Stroke!

Presenter: Nick Hopkins, Aman B. Patel, Adnan Siddiqui

November 01, 2017

Presentation TCT 2017

Flash Debate 1: Is Intervention for Asymptomatic Carotid Stenosis Indicated Given Modern Medical Management? No, the Data Are Clear!

Presenter: Brian G. DeRubertis, D. Christopher Metzger, Klaus D. Mathias

November 01, 2017

Presentation TCT 2017

Flash Debate 1: Is Intervention for Asymptomatic Carotid Stenosis Indicated Given Modern Medical Management? Yes, the Data Are Clear!

Presenter: Brian G. DeRubertis, D. Christopher Metzger, Christopher J. White

November 01, 2017

Presentation TCT 2017

Flash Debate: Surgery Remains the First Option in All Operable Patients With Bicuspid Aortic Stenosis!

Presenter: Gilles Dreyfus, Sanjay Kaul, Alfredo Trento

November 01, 2017

Presentation TCT 2017

Flash Debate: Enough Evidence Is Present to Justify TAVR in Select Patients With Bicuspid Aortic Stenosis!

Presenter: Gilles Dreyfus, Sanjay Kaul, John G. Webb

November 01, 2017

Presentation TCT 2017

Flash Debate: Surveillance and Prophylactic Treatment of Asymptomatic TAVR Thrombosis Is Not Currently Warranted!

Presenter: Gilles Dreyfus, Sanjay Kaul, Hendrik Treede

November 01, 2017

Presentation TCT 2017

Flash Debate: Valve Thrombosis After TAVR Is a Serious Concern That Deserves Detection and Management!

Presenter: Gilles Dreyfus, Sanjay Kaul, Raj Makkar

November 01, 2017

Presentation TCT 2017

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Duane S. Pinto

November 01, 2017

Advertisement

Does Tricuspid Leaflet Grasping Make Sense As a Primary or Adjunctive TR Therapy?

One-stop Shopping: Once TMVR Is Refined, Clearly the Preferred Therapy for Most MR Patients

Leaflet Chordal Suspension for Primary MR Will Importantly Augment the Surgical/Interventional Toolbox

Transcatheter Mitral Annuloplasty Devices Will Be the "Centerpiece" in the Future

Cant Beat Safety and Simplicity: Transcatheter Leaflet Approximation Technologies Will Continue to Dominate

NO: The Data Are Weak and the Costs Are Prohibitive!

YES: Review of ALL the Data and Common Sense Tell the Story!

Cedars-Sinai Medical Center (USA)

Erasmus University (The Netherlands)

Ulm University (Germany)

Flash Debate 3: Should the Rapidly Improving and Asymptomatic Patient With Significant Vessel Occlusion Be Treated (and When)? No!

Flash Debate 3: Should the Rapidly Improving and Asymptomatic Patient With Significant Vessel Occlusion Be Treated (and When)? Yes!

Flash Debate 2: I Favor Conscious Sedation Over General Anesthesia in Acute Stroke!

Flash Debate 1: Is Intervention for Asymptomatic Carotid Stenosis Indicated Given Modern Medical Management? No, the Data Are Clear!

Flash Debate 1: Is Intervention for Asymptomatic Carotid Stenosis Indicated Given Modern Medical Management? Yes, the Data Are Clear!

Flash Debate: Surgery Remains the First Option in All Operable Patients With Bicuspid Aortic Stenosis!

Flash Debate: Enough Evidence Is Present to Justify TAVR in Select Patients With Bicuspid Aortic Stenosis!

Flash Debate: Surveillance and Prophylactic Treatment of Asymptomatic TAVR Thrombosis Is Not Currently Warranted!

Flash Debate: Valve Thrombosis After TAVR Is a Serious Concern That Deserves Detection and Management!

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content